Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 160 is a member of the RN7SKP pseudogene family and is a non-functional genomic sequence that resembles the functional RN7SK gene. Unlike RN7SK, a small nuclear RNA involved in regulating RNA polymerase II transcription and cell cycle control through complex ribonucleoprotein assemblies, RN7SKP160 is presumed to be noncoding, lacking evidence for biological activity, disease association, or druggability. Pseudogenes such as RN7SKP160 are generally not targeted in biomedical research or therapy and should not be confused with their functional gene counterparts[3][4][2][1]. If you intended to query the functional RN7SK small nuclear RNA (rather than its pseudogene), please clarify, as the latter has distinct regulatory and disease connections[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 160 (RN7SKP160).